0001127602-17-021004.txt : 20170608
0001127602-17-021004.hdr.sgml : 20170608
20170608202142
ACCESSION NUMBER: 0001127602-17-021004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170607
FILED AS OF DATE: 20170608
DATE AS OF CHANGE: 20170608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COOPER COMPANIES INC
CENTRAL INDEX KEY: 0000711404
STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851]
IRS NUMBER: 942657368
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1031
BUSINESS ADDRESS:
STREET 1: 6140 STONERIDGE MALL RD
STREET 2: STE 590
CITY: PLEASANTON
STATE: CA
ZIP: 94588
BUSINESS PHONE: 9254603600
MAIL ADDRESS:
STREET 1: 6140 STONERIDGE MALL ROAD
STREET 2: SUITE 590
CITY: PLEASANTON
STATE: CA
ZIP: 94588
FORMER COMPANY:
FORMER CONFORMED NAME: COOPERVISION INC
DATE OF NAME CHANGE: 19870701
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KAUFMAN CAROL R
CENTRAL INDEX KEY: 0001181958
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-08597
FILM NUMBER: 17901373
MAIL ADDRESS:
STREET 1: 6140 STANERIDGE MALL RES #590
CITY: PLEASSANTON
STATE: CA
ZIP: 94503
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2017-06-07
0000711404
COOPER COMPANIES INC
COO
0001181958
KAUFMAN CAROL R
6140 STONERIDGE MALL DRIVE
SUITE 590
PLEASANTON
CA
94588
1
EVP, Sec. & Chief Gov. Officer
Common Stock
2017-06-07
4
M
0
16500
13.21
A
60419
D
Common Stock
2017-06-07
4
M
0
8500
13.10
A
68919
D
Common Stock
2017-06-07
4
S
0
1500
242.6687
D
67419
D
Common Stock
2017-06-07
4
S
0
23500
243.2628
D
43919
D
Common Stock
2017-06-08
4
M
0
19092
13.10
A
63011
D
Common Stock
2017-06-08
4
S
0
19092
242.2605
D
43919
D
Stock Options (Right to Buy)
13.21
2017-06-07
4
M
0
16500
0
D
2018-12-09
Common Stock
16500
0
D
Stock Options (Right to Buy)
13.10
2017-06-07
4
M
0
8500
0
D
2018-12-10
Common Stock
8500
24500
D
Stock Options (Right to Buy)
13.10
2017-06-08
4
M
0
19092
0
D
2018-12-10
Common Stock
19092
5408
D
Sale price represents an average of sale prices ranging from $242.5850 to $242.8100.
Sale price represents an average of sale prices ranging from $242.9200 to $243.8500.
Sale price represents an average of sale prices ranging from $242.0000 to $242.6300.
All shares granted under this option are currently exercisable.
/s/ Carol R. Kaufman
2017-06-08